Hologic Receives Expanded FDA 510(k) Clearance to Market Cynosure's SculpSure(R) for Non-Invasive Body Contouring (Lipolysis) of Back, Inner and Outer Thighs

SculpSure Now Cleared to Treat Five Areas of the Body MARLBOROUGH, Mass., June 15, 2017 -- (Healthcare Sales & Marketing Network) -- Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted an expanded c... Devices, FDA Hologic, Cynosure, SculpSure, body contouring
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news